Topic

Photrexa (riboflavin ophthalmic solution)

A collection of 29 issues

How to Get Photrexa (Riboflavin) Covered by Aetna CVS Health in Florida: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Photrexa Covered by Aetna CVS Health in Florida Photrexa (riboflavin ophthalmic solution) requires prior authorization from Aetna CVS Health in Florida. Submit PA request through Availity provider portal with: keratoconus progression documentation (Kmax values), failed conservative treatments, FDA-approved iLink system confirmation. Standard decision: 30-45 days. If denied,
6 min read

How to Get Photrexa (Riboflavin) Covered by Aetna CVS Health in Texas: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Photrexa Covered by Aetna CVS Health in Texas Aetna CVS Health covers Photrexa (riboflavin ophthalmic solution) for corneal cross-linking in progressive keratoconus, but requires prior authorization with documented progression. Key requirements: serial corneal topography showing ≥1 diopter Kmax increase over 12 months, minimum corneal thickness ≥400 microns,
6 min read

How to Get Photrexa (Riboflavin) Covered by Aetna CVS Health in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Photrexa Covered by Aetna CVS Health in New York Yes, Aetna CVS Health covers Photrexa (riboflavin ophthalmic solution) for progressive keratoconus with prior authorization. To get approved in New York: (1) Your cornea specialist submits prior authorization with serial topography showing progression, (2) Aetna typically decides within
6 min read

How to Get Photrexa (Riboflavin Ophthalmic Solution) Covered by UnitedHealthcare in Michigan: Prior Authorization Timeline & Appeals Guide

Answer Box: Getting Photrexa Covered in Michigan Photrexa (riboflavin ophthalmic solution) requires prior authorization from UnitedHealthcare for corneal cross-linking in progressive keratoconus. The fastest path to approval: (1) Submit PA through the UHC Provider Portal with serial topography showing ≥1 diopter Kmax progression over 12 months, (2) Include pachymetry confirming
5 min read

Get Photrexa Covered by UnitedHealthcare in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Get Photrexa Covered by UnitedHealthcare in New York UnitedHealthcare covers FDA-approved Photrexa (riboflavin ophthalmic solution) for progressive keratoconus with prior authorization, but only for epithelium-off procedures using the iLink® system. In New York, if denied, you have strong appeal rights through the Department of Financial Services with expedited
7 min read

How to Get Photrexa Covered by UnitedHealthcare in Ohio: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Photrexa Covered by UnitedHealthcare in Ohio UnitedHealthcare requires prior authorization for Photrexa (riboflavin ophthalmic solution) corneal cross-linking in Ohio. Coverage is limited to FDA-approved epithelium-off iLink® procedures for progressive keratoconus with documented worsening (≥1 diopter Kmax increase over 12 months). First step: Have your ophthalmologist submit a
5 min read

How to Get Photrexa (Riboflavin) Covered by Humana in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Photrexa Covered by Humana in New Jersey Humana Medicare Advantage requires prior authorization for Photrexa (riboflavin ophthalmic solution) used in corneal cross-linking for progressive keratoconus. Approval depends on documented progression (Kmax increase ≥1.0 diopter over 6-12 months) and use of FDA-approved epithelium-off protocols at certified facilities.
6 min read

How to Get Photrexa (Riboflavin) Covered by Cigna in New Jersey: Prior Authorization Guide with Appeals Timeline

Answer Box: Getting Photrexa Covered by Cigna in New Jersey Photrexa (riboflavin ophthalmic solution) requires prior authorization from Cigna in New Jersey. The fastest path to approval: (1) Submit complete PA request with corneal topography showing progression, (2) Include medical necessity letter from ophthalmologist citing FDA-approved epithelium-off cross-linking protocol, (3)
6 min read